Skip to main content

mycophenolate

Generic: MYCOPHENOLATE SODIUM·Brand: MYCOPHENOLATE SODIUM, MYFORTIC

mycophenolate: 3 clinical trials tracked.

mycophenolate evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about mycophenolate, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 2 study sponsors
Clinical Trials (3)

A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients

NCT07412470·Phase 2/Phase 3·SNY
Recruiting

Primary endpoint: Composite efficacy failure rate (BPAR, graft loss, and death) by 1 year post kidney transplantation

InterventionalRandomizedopen526 targetStarted 2026-03Completion 2033-0826 sites · Argentina, Australia, Belgium, Chile…Sanofi

A Multi-cohort, Randomized, Phase 2, Open-label Study to Assess the Preliminary Efficacy, Safety, and Pharmacokinetics of BIVV020 for Prevention and Treatment of Antibody-mediated Rejection in Adult Kidney Transplant Recipients.

NCT05156710·Phase 2·SNY
Active, not recruiting

Primary endpoint: Cohort A: Treatment failure rate

InterventionalRandomizedopen48 enrolledStarted 2022-06Completion 2026-1027 sites · Canada, France, Germany, Italy…Sanofi

Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis: a 12 Month, Single-arm, Observational Study in Taiwan Population

NCT04645589·NVS
Completed

Primary endpoint: Safety profile of Enteric-coated Mycophenolate Sodium (EC-MPS) on Lupus nephritis patients

Observational69 enrolledStarted 2021-03Completion 2025-086 sites · TaiwanNovartis Pharmaceuticals